Related Experiment Video
Updated: Aug 7, 2026

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Early Diagnosis and Successful Treatment of Influenza Coinfection With Community-Onset Methicillin-Resistant
Po-Kai Chan1,2, Chun-Han Wu1,3
1Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ndmctsgh.edu.tw.
Background:
Necrotizing pneumonia is a severe and potentially fatal complication of community-acquired pneumonia, often associated with toxin-producing or drug-resistant pathogens. Rapid and accurate identification of these pathogens is crucial for timely intervention. Polymerase chain reaction (PCR)-based diagnostic tools, such as the BioFire FilmArray pneumonia panel, have significantly improved early pathogen detection, aiding in prompt and targeted treatment as in the presenting case.
Case Report:
We report a case of necrotizing pneumonia in a female adult who presented with severe respiratory distress. Initial testing identified coinfection with influenza and methicillin-resistant Staphylococcus aureus (MRSA) using the BioFire FilmArray pneumonia panel, which provided rapid and precise pathogen detection before admission. The patient developed worsening respiratory failure, requiring mechanical ventilation and intensive care. Despite the severity of the infection, early diagnosis and appropriate antimicrobial therapy tailored to the identified pathogens led to a significant clinical improvement, allowing for a favorable recovery.
Conclusion:
This case highlights the critical role of rapid molecular diagnostics in the early detection of coinfections in necrotizing pneumonia. The timely identification of influenza and MRSA facilitated targeted antimicrobial therapy, which was instrumental in preventing further complications and improving the patient's prognosis. As PCR-based diagnostics become more widely available, their integration into routine clinical practice can enhance the management of severe pneumonia cases, ultimately leading to better outcomes. Clinicians should maintain a high index of suspicion for coinfections in severe pneumonia and leverage rapid diagnostic tools to guide early and effective treatment strategies.
Insights
Rapid molecular diagnostics accurately identified coinfections in necrotizing pneumonia, leading to timely treatment and favorable outcomes. Early pathogen detection is crucial for managing severe respiratory infections.
Area of Science:
- Infectious Diseases
- Molecular Diagnostics
- Pulmonology
Background:
- Necrotizing pneumonia is a severe complication of community-acquired pneumonia.
- It is often caused by toxin-producing or drug-resistant pathogens.
- Rapid pathogen identification is critical for effective treatment.
Purpose of the Study:
- To highlight the role of rapid molecular diagnostics in identifying coinfections in necrotizing pneumonia.
- To emphasize the impact of timely diagnosis and targeted therapy on patient outcomes.
- To advocate for the integration of PCR-based diagnostics in managing severe pneumonia.
Main Methods:
- Case report of a female adult with necrotizing pneumonia.
- Utilized the BioFire FilmArray pneumonia panel for rapid pathogen detection.
- Initial testing identified coinfection with influenza and methicillin-resistant Staphylococcus aureus (MRSA).
Main Results:
- The BioFire FilmArray provided rapid and precise identification of influenza and MRSA coinfection.
- The patient experienced worsening respiratory failure, requiring mechanical ventilation.
- Early diagnosis and targeted antimicrobial therapy led to significant clinical improvement and recovery.
Conclusions:
- Rapid molecular diagnostics are critical for early detection of coinfections in necrotizing pneumonia.
- Timely identification of pathogens like influenza and MRSA enables targeted antimicrobial therapy.
- Integrating PCR-based diagnostics into clinical practice can improve management and outcomes for severe pneumonia.
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
13:45A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
Published on: September 21, 2019
Related Concept Videos
Cryptococcal Meningitis
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...